Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma
Clinical trial NCT01973062 · TERMINATED
Trial details
- NCT number
- NCT01973062
- Sponsor
- Case Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-06-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.